Total Visits

Views
A personalized medicine ex vivo test to predict clinical response to first line induction therapy with idarubicin and cytarabine in patients with acute myeloid leukemia4

Select a period of time:

Views

Views
November 20230
December 20231
January 20241
February 20240
March 20240
April 20240
May 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
 

Top cities views

Views
Boardman2